Viewing Study NCT03328559


Ignite Creation Date: 2025-12-24 @ 2:55 PM
Ignite Modification Date: 2026-02-24 @ 2:46 AM
Study NCT ID: NCT03328559
Status: COMPLETED
Last Update Posted: 2021-08-23
First Post: 2017-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Kinetics of Circulating Tumoral Cells in Bronchial Primitive Cancer
Sponsor: Fondation Hôpital Saint-Joseph
Organization:

Study Overview

Official Title: Kinetics of Circulating Tumoral Cells in Bronchial Primitive Cancer
Status: COMPLETED
Status Verified Date: 2021-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The pronostic value of Circulating Tumoral Cells(CTC) 's dosage by the method ISET® (tumoral cell isolation by size) in patients with bronchial cancer was previously demonstrated.

However, no kinetic study was ever realized to study the value of the CTC as predictive indicator of answer to the therapy. This project plans to study patients in an early stage and patients at advance stage locally moved forward or metastatic of the disease by evaluation of the presence and the number of CTC before every cure. This collaborative and original study should allow to refine the diagnoses of answer and to plan the possible relapses what would allow a premature institution of the treatment.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: